Vilnius, Lithuania
Meliva Kardiolita Hospital Vilnius
Hospital details:
Hospital name:
Meliva Kardiolita Hospital Vilnius
Hospital city:
Vilnius
Hospital country:
Lithuania
Nearest international airport:
Vilnius airport
Hospital director:
Andrius Kostagriz
Total number of beds:
36
Total medical staff:
500
Total annual treatments:
2871
Hospital overview:
Meliva Kardiolita Hospital, located in the Lithuanian capital of Vilnius, is one of the leading private hospitals in the Baltic region and a trusted partner for My Medical Gateway patients seeking high-quality care in Europe. The hospital is accredited by the Joint Commission International (JCI), the globally recognised gold standard for patient safety, clinical governance and hospital management. This accreditation confirms that every procedure and policy at Kardiolita follows the same evidence-based standards required of major UK and Western European institutions.
Scale, Facilities and Management:
Kardiolita operates within the Meliva Healthcare Group (formerly InMedica Group and Kardiolita Clinics), a national network that unites hospital and outpatient services under common clinical protocols and standards. Across Lithuania, Meliva employs over 600 staff and 500 doctors in 45 medical specialties and provides treatment for approximately 298,000 patients each year.
The Vilnius hospital is a medium-sized, multi-specialty centre with around 50 inpatient beds, a 10-bed intensive care unit and four fully equipped operating theatres capable of handling high-complexity cardiac, orthopaedic, and general surgical cases.
The hospital is directed by Andrius Kostogriz, responsible for overall governance and international partnerships. Under his leadership, Kardiolita has expanded its clinical research links with European institutions and maintained continuous JCI compliance since its original accreditation.
Medical Leadership and Key Specialists:
Kardiolita’s medical team combines senior Lithuanian consultants with international training. Among its most experienced specialists are:
Prof. Giedrius Uždavinys, senior cardiac surgeon, who has performed thousands of coronary and valve procedures over five decades of practice;
Prof. Audrius Aidietis, interventional cardiologist and electrophysiology specialist;
Dr. Antanas Mickevičius MD PhD, Consultant bariatric and upper-gastrointestinal surgeon, who also practises in the UK NHS at the Royal Stoke University Hospital and performs roughly 200 bariatric procedures per year;
Dr. Justinas Vaičiulis, orthopaedic and trauma surgeon specialising in minimally invasive shoulder, knee and hip reconstruction;
Dr. Vaidotas Zabulis and Dr. Arūnas Grinkevičius, vascular surgeons recognised for expertise in endovenous laser therapy and arterial bypass techniques.
Clinical Services and Technology:
Kardiolita provides an integrated model of diagnosis, surgery and rehabilitation across cardiology, cardiac surgery, orthopaedics, bariatric surgery, general surgery, plastic and reconstructive surgery, urology and gynaecology.
Its diagnostic facilities include digital MRI and CT imaging, angiography suites and minimally invasive endoscopic systems. Surgical theatres are equipped for laparoscopic, arthroscopic and endovascular procedures, reducing recovery time and the need for prolonged hospitalisation.
A rehabilitation centre within the Meliva network provides physiotherapy, wound care and post-operative cardiac and musculoskeletal rehabilitation, enabling patients to complete recovery in a coordinated setting before returning home.
Performance and Outcomes:
Publicly available clinical data and independent international directories indicate strong performance across major disciplines:
Cardiac surgery: success rates exceeding 95 %, with coronary artery bypass grafting survival reported at 99 % for standard-risk patients.
Orthopaedics: average post-operative complication rate ≈ 3 %, with prosthetic joint lifespan of 17–18 years.
Bariatric surgery: complication rate 3–5 %, achieving 40–100 % excess-weight reduction within two years, depending on the procedure.
These statistics originate from audited hospital reporting and verified healthcare directories and demonstrate consistent performance levels comparable with Western European benchmarks.
Patient Safety and Quality Assurance:
Kardiolita’s infection-control programme meets JCI Category I infection-prevention standards, with continuous surveillance and antibiotic stewardship. All intensive-care patients are monitored by consultant anaesthetists 24 hours a day. Surgical pathways follow European Society of Anaesthesiology guidelines for thromboembolism prophylaxis and peri-operative antibiotic timing.
Coordination with MMG:
For patients introduced to Kardiolita by MMG, all arrangements — from initial online consultation to admission, treatment and post-operative follow-up — are managed by an English-speaking international coordination team that are fluent in English. Pre-treatment assessments, laboratory tests and imaging can be organised within 48 hours of arrival, with most patients requiring hospital stays of two to five days, depending on procedure complexity.
Rehabilitation and Continuing Care:
Rehabilitation begins immediately after surgery, guided by physiotherapists and specialist nurses. Cardiac patients enter structured exercise and monitoring programmes, while orthopaedic and bariatric patients receive detailed physiotherapy schedules and nutritional support. The Meliva network also provides tele-consultations and imaging reviews for patients once they return home, maintaining continuity of care.
Interested?
This hospital offers the following treatments:
